PolyPeptide Group AGXSWX:PPGN +4.38%74 OCF Margin % is 12.42% as of Dec. 2025, which is 38% below its 10-year median of 19.92. GuruFocus rates XSWX:PPGN with a GF Score™ of 74/100 and a GF Value™ of CHF30.72 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 956 Drug Manufacturers companies, PolyPeptide Group AG ranks better than 76.88% on this metric.
The historical rank and industry rank for PolyPeptide Group AG's OCF Margin % or its related term are showing as below:
XSWX:PPGN'
s OCF Margin % Range Over the Past 10 Years
Min: 1.93 Med: 19.92 Max: 27.32
Current: 19.8
During the past 8 years, the highest OCF Margin % of PolyPeptide Group AG was 27.32%. The lowest was 1.93%. And the median was 19.92%.
XSWX:PPGN's OCF Margin % is ranked better than 76.88% of 956
companies
in the Drug Manufacturers industry
Industry Median: 9.985
vs XSWX:PPGN: 19.80
PolyPeptide Group AG OCF Margin % Related Terms
PolyPeptide Group AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for PolyPeptide Group AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:PPGN vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PolyPeptide Group AG OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PolyPeptide Group AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PolyPeptide Group AG (XSWX:PPGN) has a OCF Margin % of 12.42% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PolyPeptide Group AG and its competitors. This is 38% below median its historical median of 19.92. Over the past decade, PolyPeptide Group AG's OCF Margin % has ranged from 1.93 to 27.32. According to the industry distribution chart, PolyPeptide Group AG ranks #221 out of 956 companies in the Drug Manufacturers industry, placing it in the top 23.1%.
Is PolyPeptide Group AG's OCF Margin % too high?
PolyPeptide Group AG's current OCF Margin % of 12.42% is 38% below median its 10-year median of 19.92. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 27.32. The Drug Manufacturers industry median OCF Margin % is 9.99. PolyPeptide Group AG's value of 12.42% is 24.4% above this industry median. Based on the distribution chart, PolyPeptide Group AG ranks #221 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PolyPeptide Group AG has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PolyPeptide Group AG ranks #221 out of 956 companies for OCF Margin %. This places PolyPeptide Group AG in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. PolyPeptide Group AG's value of 12.42% is 24.4% above this benchmark. Historically, PolyPeptide Group AG's own OCF Margin % has ranged from 1.93 to 27.32 over the past decade. While the company's 10-year median is 19.92 vs. the industry median of 9.99, PolyPeptide Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PolyPeptide Group AG's current OCF Margin % of 12.42% is 24.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PolyPeptide Group AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PolyPeptide Group AG's current OCF Margin % is 12.42%, which is 38% below median its own 10-year median of 19.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (XSWX:PPGN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF30.72, compared to a current price of CHF46.50 — trading 51.4% above its estimated fair value. The current OCF Margin % is 12.42%, which is 38% below median its 10-year median of 19.92 and 24.4% above the Drug Manufacturers industry median of 9.99. PolyPeptide Group AG's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PolyPeptide Group AG (XSWX:PPGN), the current OCF Margin % is 12.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PolyPeptide Group AG (XSWX:PPGN) Overvalued in 2026?
Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued.
The current stock price of CHF46.50 is trading 51.4% above its estimated GF Value™ of CHF30.72.
GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.
Key valuation signals for XSWX:PPGN:
OCF Margin %: 12.42% (38% below median its 10-year median of 19.92)
GF Value™: CHF30.72 vs. price of CHF46.50 (51.4% above fair value)
Industry Position: 24.4% above the Drug Manufacturers median (#221 of 956)
No single metric tells the full story. See the XSWX:PPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
74GF Score
Get the complete analysis for XSWX:PPGN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:PPGN has been successfully added to your 
